Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{167480,
        author = {Ameya lanjewar and Dr. Dindayal Patidar},
        title = {RP-HPLC Method for Development, Validation and Assay of Desidustat in Pharmaceutical Formulation},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {3},
        pages = {1685-1698},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=167480},
        abstract = {Desidustat is an orally bioavailable, hypoxia- inducible factor prolyl hydroxylase inhibitor and used to treat anemia of chronic kidney disease. An accurate, precise and robust reverse phase HPLC methods was developed and validated as per ICH guideline. An analytical column eclipse XDB C18 (150x4.6 mm,5µ) was used at flow rate 1.0 ml/min in the mobile phase ratio of 0.1% orthophosphoric acid and methanol 38:72 at 235 nm wavelength. These approach can be effectively utilized for the development and validation of desidustat in pharmaceutical formulation.},
        keywords = {Desidustat, Eclipse XDB C18 (150x4.6 Mm,5µ), RP-HPLC, Development And Validation},
        month = {September},
        }